Molecular analysis of HLA-DPB1 Alleles in idiopathic systemic sclerosis patients and uranium miners with systemic sclerosis

International Archives of Allergy and Immunology

Volumn 109, Issue 3, 1996, Pages 216-222

  Rihs, H P ^a   Conrad, K ^b   Mehlhorn, J ^c   May Taube, K ^a   Welticke, B ^a   Frank, K H ^b   Baur, X ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c ärztliche Gutachtergemeinschaft Niederdorf   (Germany)

Author keywords

Caucasians; HLA DPB1; Irradiation; Silica dust; Systemic sclerosis

Indexed keywords

AMINO ACID; AUTOANTIBODY; HLA DP ANTIGEN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MALE; MOLECULAR BIOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STATISTICAL ANALYSIS; SYSTEMIC SCLEROSIS; URANIUM MINE;

EID: 0030041397     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000237240     Document Type: Article

References (29)

1. LeRoy EC, Black C, Fleishmayer R, Jablonska S, Krieg T, Medsger TA, Rowell N, Wollheim F: Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis.J Rheumatol 1988:15:202 205.
2. Steen VD. Powell DL. Medsger TA Jr: Clinical correlations and prognosis based on scrum autoantibodies in patients with progressive systemic sclerosis. Arthritis Rheum 1988:31:196-203.
3. Catoggio IJ, Bernstein RM, Black CM, Hughes GRV, Maddison PJ: Serological markers in progressive systemic sclerosis: Clinical correlations. Ann Rheum Dis 1983:42:23-27.
4. Steen VD. Ziegler GL. Rodnan GP. Medsger TA: Clinical and laboratory associations of anti-centromere antibody in patients with progressive systemic sclerosis. Arthritis Rheum 1984: 27:125-131.
5. Douvas AS. Achten M. Ian EM: Identification of a nuclear protein (Sci 70) as a unique target of human anti-nuclear antibodies in scleroderma. J Biol Chem 1979:254:10514-10522.
6. Tan EM: Anlinuelear antibodies: Diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 1989:44:93-151.
7. Weiner F.S. Earnshaw WC, Senecal JL, Bordwell B, Johnson P, Rothfield NF: Clinical associations of anticentromere antibodies and au-toantibodics to topoisomerase I: A study of 355 patients. Arthritis Rheum 1988:31:378-385.
8. Briggs DC. Welsh KI, Pereira RS, Black CM: A strong association between null alleles at the C4A locus in the major histocompatibility complex and systemic sclerosis. Arthritis Rheum 1986:29:1274-1277.
9. Briggs DC, Vaughan RW, Welsh KI, Myers A, DuBois RM, Black CM: Immunogenetic prediction of pulmonary fibrosis in systemic sclerosis. Lancet 1991:338:661-662.
10. Black CM. Welsh KI, Maddison PJ, Jayson MIV, Bernstein RM: HLA antigens.autoantibodies and clinical subsets in scleroderma. Br J Rheumatol 1984:23:267-271.
11. Barnett AJ. Tail BD. Barnett MA. Toll BH: T lymphocyte subset abnormalities and HLA antigens in scleroderma (systemic sclerosis). Clin Exp Immunol 1989;76:24-29.
12. Genth E, Micrau R, Genetzky P, von Mühlen CA, Kaufmann S, von Wilmowsky H, Meuter M, Krieg T, Pollmann HJ, Hartl PW: Immunogenetic associations of scleroderma-related an-tinuclcar antibodies. Arthritis Rhcum 1990:33: 657-665.
13. Dunekley H. Jazwinska EC. Gatcnby PA. Serc-jeantson SW: DNA-DR typing shows IILA-DRwll RFLPs are increased in frequency in both progressive systemic sclerosis and CREST variants of scleroderma. Tissue Antigens 1989: 33:418-420.
14. Reveille JD. Owerbach D. Goldstein R. Moreda R. Isem RA. Arnett FC: Association of polar amino acids at position 26 of the HLA-DQBI first domain with the anticentromcre autoantibody response in systemic sclerosis scleroderma. J C lin Invest 1992;89:1208-1213.
15. Reveille JD: Molecular genetics of systemic sclerosis. Curr Opin Rheumatol 1993:5:753-759.
16. Briggs D. Stephens C, Vaughan R. Welsh K, Black C: A molecular and serologic analysis of the major histocompatibility complex and complement component C4 in systemic sclerosis. Arthritis Rheum 1993;36:943-954.
17. Reveille JD. Durban E. MacLeod-St Clair MJ. Goldstein R. Moreda R. Altman RD. Arnett FC: Association of amino acid sequences in the HLA-DQB1 first domain with the antitopoi-somerase I autoantibody response in scleroderma (progressive systemic sclerosis). J Clin Invest 1992:90:973-980.
18. Beck B, Irmscher G, Zschunke E: Silikose and Sklerodermine - Versuch einer Synopsis. Z Ge-santtc Inn Med 1976;31:493-496.
19. Kimura A, Sasazuki T: 11 th International Histocompatibility Workshop reference protocol for the HLA DNA typing technique; in Tsuji K. Ai-zawa M. Sasazuki T (eds): HLA 1991 Oxford, Oxford University Press. 1991. vol. I pp397-419.
20. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23:581-590.
21. Nevinny-Stickel C. Hinzpeter M. Andreas A. Albert ED: Nonradioactive oligotyping for HLA-DR I-DRw 10 using polymerase chain reaction. digoxigenin-labelled oligonucleotides and chemiluminiscence detection. EurJ Immunogen 1991:18:323-332.
22. Rihs HP, Thiele A, Perichon B, Krishnamoorthy R, Baur X: DNA typing with digoxigcnin-l I-dideoxyuridinctriphosphatc-labellcd oligonucleotide probes enables non-radioactive analysis using a dual detection system: Application for screening HLA-DQAI polymorphisms. Int Arch Allergy Immunol 1993;101:7-12.
23. Ryder LP. Svcjgaard A: Histocompatibility associated diseases; in Loor F. Roelants GE (eds): T and B Lymphocytes in Immune Responses. New York. Wiley, 1977. pp 437-456.
24. Rihs HP, Conrad C, Mehlhorn J, May-Taube K, Welticke B, Frank KH, Baur X: Untersuchung über die Assoziation zwischen HLA-D-Allelen und dem Auftreten sklcrodermietypischer Autoantikörper unter quarzstaubexponierten Personen. Z Ärztl Fortbild 1994:88:513-518.
25. Reveille JD. Brady J. McLeod-St Clair M. Durban E: HLA-DPB1 alleles and autoantibody subsets in systemic lupus erythematosus. Sjogren's syndrome and progressive systemic sclerosis: A question of disease relevance. Tissue Antigens 1992;40:45-48.
26. Kuwana M, Kaburaki J, Okano Y, Inoko H, Tsuji K: The HLA-DR and DQ genes control the autoimmune response to DNA topoisomcrase I in systemic sclerosis (scleroderma). J Clin Invest 1992:92:1296-1301.
27. Naruse T. Nose Y, Tsuji K, Inoko H: Strong and unique associations of IILA-DPB 1 alleles with other HLA antigens in a Japanese population. Tissue Antigens 1992:39:276-279.
28. Takeuchi F. Nakano K. Yamada H. Hong GH. Nabeta H. Yoshida A. Matsuta K. Bannai M. To-kunaga K. Ito K: Association of FILA-DR with progressive systemic sclerosis in Japanese. J Rheumatol 1994;21:857-863.
29. Richeldi L. Sorrcntino R. Saltini C: HLA-DPBI glutamate 69: A genetic marker of beryllium disease. Science 1993:262:242-244.